Carpal Tunnel Syndrome Treatment in India and UAE | Complete Patient Guide

• Confirmed median neuropathy on electrodiagnostic testing (NCV/EMG) with distal sensory latency > 3.5 ms or distal motor latency > 4.5 ms

• Clinical staging: mild to severe CTS unresponsive to ≥ 6 weeks of conservative management (neutral-position splinting, corticosteroid injection)

• Thenar muscle wasting or objective loss of two-point discrimination (> 6 mm static), indicating advanced nerve compromise warranting urgent surgical referral

• Occupational or lifestyle-related CTS (prolonged keyboard use, vibratory tool exposure, repetitive flexion-extension work) in patients who have failed ergonomic modification

• Secondary CTS associated with systemic conditions: rheumatoid arthritis, hypothyroidism, diabetes mellitus, acromegaly, amyloidosis, pregnancy-related—with the underlying condition optimally managed pre-operatively

• Recurrent CTS following prior incomplete release, requiring revision surgery with neurolysis

Required Pre-operative Diagnostics:

• Nerve Conduction Studies (NCS) + EMG — mandatory severity stratification and surgical planning

• High-resolution median nerve ultrasound — cross-sectional area measurement, synovial hypertrophy assessment

• Full blood count, HbA1c, thyroid function panel (TSH/Free T4) — to detect contributing systemic pathology

• Coagulation profile (PT/INR/aPTT) — pre-anaesthesia requirement

• ECG and physician clearance for patients > 50 years or with cardiovascular comorbidities

Contraindications / Factors Requiring Optimisation Before Proceeding:

• Active local skin infection or cellulitis overlying the surgical site

• Uncontrolled coagulopathy or anticoagulant therapy not bridged appropriately

• Alternative diagnoses not excluded: cervical radiculopathy (C6–C7), pronator teres syndrome, thoracic outlet syndrome, or peripheral polyneuropathy — these require exclusion by MRI cervical spine or upper-limb neurophysiology before CTR is performed

• Poorly controlled diabetes (HbA1c > 9%) — associated with impaired wound healing and higher infection risk; optimisation recommended before elective surgery

• Severe thenar atrophy with absent median CMAP on EMG — functional prognosis should be counselled carefully, as motor recovery may be incomplete even after technically successful decompression

**1. Conservative (Non-Surgical) Management** Indicated for mild-to-moderate CTS, pregnancy-related CTS, or patients unfit for surgery. The primary intervention is a custom-moulded or prefabricated wrist orthosis worn in the neutral (0°) position, particularly at night, reducing intracarpal pressure to physiological levels during sleep. A single ultrasound-guided corticosteroid injection (methylprednisolone 40 mg or triamcinolone 20–40 mg with 1% lidocaine) delivers superior depot placement versus landmark-guided technique and provides meaningful symptom relief for 2–4 months in up to 80% of patients, serving as a useful bridge or diagnostic-therapeutic tool. Oral anti-inflammatory agents, B6 supplementation (evidence limited), and structured hand therapy / ergonomic retraining complement immobilisation. Iontophoresis and low-level laser therapy are adjunctive modalities with emerging supportive data.

**2. Open Carpal Tunnel Release (OCTR)** The gold-standard surgical technique with the longest safety record. Under local anaesthesia with intravenous sedation or regional Bier block (lignocaine 0.5%), a 2–4 cm longitudinal incision is made along the thenar crease ulnar to the recurrent motor branch of the median nerve. The transverse carpal ligament is divided under direct vision, with optional internal neurolysis and synovectomy in revision or inflammatory cases. Advantages include complete ligament division under direct visualisation, suitability for complex or recurrent cases, and the lowest rate of incomplete release (< 1%). The main disadvantage versus endoscopic technique is a slightly longer scar tenderness and return-to-work timeline.

**3. Endoscopic Carpal Tunnel Release (ECTR)** The minimally invasive standard, available in two validated systems: single-portal (Agee) and dual-portal (Chow). A 1–2 cm proximal incision admits the endoscope into Guyon's canal plane; the transverse carpal ligament is divided from inside out using a retractable blade under camera visualisation on a high-definition monitor. ECTR delivers equivalent long-term outcomes to OCTR with statistically significant advantages: smaller scar, reduced pillar pain, faster return to work (mean 2 weeks versus 4–6 weeks for OCTR), and lower short-term morbidity. It is the preferred technique in GAF Healthcare-partnered centres in India and the UAE for straightforward primary CTS.

**4. Ultrasound-Guided Percutaneous Needle Release (UPNR / Hydrodissection)** An office-based, needle-only technique where a bevelled needle is used under real-time ultrasound guidance to serially release the transverse carpal ligament fascicles while simultaneously performing hydrodissection of the median nerve from surrounding scar or tenosynovium. Evidence from randomised trials (2019–2023) shows non-inferiority to OCTR for mild-to-moderate CTS at 6 months, with near-zero downtime. Not yet universally adopted but available at select tertiary centres affiliated with GAF Healthcare.

**5. Revision / Complex Surgery** For recurrent CTS post-release, options include external neurolysis, internal neurolysis, synovectomy, flap coverage (hypothenar fat pad flap or flexor digitorum superficialis muscle flap) to protect and vascularise the median nerve, and addressing incomplete ligament division. This is performed by subspecialty hand surgeons under tourniquet control with loupe magnification or operative microscope.

**Phase 1 — Pre-Arrival (2–4 Weeks Before Travel)**

GAF Healthcare's medical coordination team reviews NCV/EMG reports, clinical photographs, and medical history submitted via the patient portal. A board-certified hand surgeon at the designated partner hospital conducts a telemedicine consultation to confirm candidacy, finalise the surgical approach, and issue the treatment plan and cost estimate. Pre-travel investigations are advised (blood work, ECG if indicated) to avoid delays on arrival. Medical visa documentation (India) or entry authorisation (UAE) is processed concurrently.

**Phase 2 — Arrival & Pre-operative Assessment (Day 1)**

Airport pickup by a GAF Healthcare representative. On Day 1, the patient attends the hospital for formal hand surgeon consultation, review of imported investigations or repeat NCV/EMG if studies are > 6 months old or technically suboptimal, anaesthesia assessment, and consent process. Blood tests, pre-operative photographs, and grip dynamometry are completed. The patient is admitted (or booked as a day-surgery case, which is typical for endoscopic release).

**Phase 3 — The Procedure (Day 1 or Day 2)**

Endoscopic CTR: Duration 15–25 minutes under local anaesthesia ± intravenous sedation. Tourniquet applied to forearm at 250 mmHg. Single- or dual-portal endoscopic ligament division confirmed on-screen. Wound closed with 2–3 absorbable subcuticular sutures. Bulky dressing applied. Patient mobilised within 1 hour; discharged same day.

Open CTR: Duration 25–45 minutes. Same anaesthetic approach. Post-operatively, the wrist is splinted for 5–7 days. Day-surgery or 1 overnight stay based on local protocol.

**Phase 4 — Immediate Post-operative Period (Days 2–7)**

Elevation of the hand above heart level for 48 hours to minimise oedema. Gentle active finger range-of-motion exercises commenced on Day 1 post-op to prevent tendon adhesion. Wound review at Day 5–7; sutures removed if non-absorbable. Oral analgesia: paracetamol 1 g QID ± short course of celecoxib 200 mg OD. Patients are typically able to perform light activities of daily living (eating, self-care) within 24–48 hours.

**Phase 5 — Outpatient Recovery & Milestones**

• Week 1–2: Scar sensitivity and pillar pain (thenar/hypothenar eminence tenderness) are normal; desensitisation massage begins at suture removal.

• Week 2–4: Grip strength progressively returns. Formal hand therapy commences—putty exercises, pinch strengthening, scar massage with silicone gel.

• Week 4–6: Return to light occupational duties (desk work, typing) for most patients.

• Week 6–12: Return to heavy manual work, sport, or vibrating tools after grip strength ≥ 80% of contralateral hand on dynamometry.

• Month 3–6: Symptom resolution (paraesthesias, nocturnal pain) typically precedes motor/grip recovery. Final outcome assessment with repeat BCTQ scoring at 3 and 6 months.

**Fit-to-Fly Milestone:**

Most patients are cleared for short-haul flights (< 4 hours) at 10–14 days post-operatively once wound is healed and swelling controlled. Long-haul intercontinental travel is advised after 2–3 weeks, with in-flight hand elevation, compression glove use, and regular fist-pump exercises to prevent dependent oedema.